Jemperli has already been approved in combination with SOC chemotherapy, followed by Jemperli as monotherapy, for the ...

Radiotherapy decisions should be made using refined genomic guidance, as recommended by 2021 updated international guidelines ...

A new nomogram is intended to identify patients at high risk for endometrial cancer and prioritize them in the hysteroscopy ...

USAFacts, a Washington-based nonprofit that compiles and reports on government data, took a deep dive into the latest cancer ...

Pesticides have gained negative attention in recent years owing to their links to biodiversity loss. But could pesticides ...

A study of nearly 600,000 people also revealed younger patients were also at a higher risk of getting another cancer after ...

A 62-year-old Ballinger woman who is the primary caretaker of her disabled husband is asking for the Concho Valley’s help in ...

Boston Micro Fabrication (BMF) introduces BMF Biotechnology, headquartered in San Diego, California. Master Bond EP30Med ...

The FDA accepted the supplemental biologics license for dostarlimab plus standard-of-care chemotherapy for all patients with ...

Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, ...

Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 ...

Clinical-stage immuno-oncology company Agenus (NASDAQ:AGEN) recently executed a 1-for-20 reverse stock split to give the ...